Jenny Johnson, founder of Maritime Inclusion Partners, possesses over 20 years of extensive maritime experience both at sea and ashore. She passionately advocates for a diverse, inclusive ...
Jenny Johnson, president and CEO of Franklin Resources, told analysts on a Jan. 31 earnings call for the quarter ended Dec. 31 that the firm’s Western Asset Management Co. fixed-income affiliate ...
Jenny Johnson is President and CEO of Franklin Templeton. In a career at Franklin Templeton spanning over 30 years, she has been a key driver in the company's transformation to what is now one of ...
Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.
Johnson's Lions offense under head coach Dan Campbell was second in yards, first in first downs and first in scoring. They were sixth in rushing and second in passing. Along the way, Johnson ...
Jimmy Johnson hinted at his potential retirement while tearing up during an emotional segment honoring his coaching career during the Fox pregame show for Super Bowl 2025. The segment included a ...
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...
It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...
The Bears are finalizing a deal, sources told the Tribune on Monday, to hire Detroit Lions offensive coordinator Ben Johnson, who was hotly pursued by the Las Vegas Raiders and Jacksonville Jaguars.
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...
Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results